Contractor directoryCompany profile
Explore awardsCompareFollowSave company

Federal contractor profile

RIGEL PHARMACEUTICALS INC

UEI X7MHPBCMHFM3CAGE 60TS7Company website ↗

Active
Small Business

Overview

Legal name
RIGEL PHARMACEUTICALS INC
Registered location
SOUTH SAN FRANCISCO, CA, USA
Website
Company website ↗
Primary NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity
May 21, 2026
Read company summary

RIGEL PHARMACEUTICALS INC is associated with UEI X7MHPBCMHFM3 and CAGE 60TS7 in public federal records. AcornBids currently links 2 prime awards totaling $750.0K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists SOUTH SAN FRANCISCO, CA, USA.

At a glance

Lifetime prime obligations$750.0K
Prime awards2
Awards with future end dates0
Top-agency concentration
Not available

Why this customer concentration

Detailed agency totals are not available in this stored profile.

Largest positive coded-agency total ÷ all positive coded-agency totals × 100

Missing data is shown as unavailable.

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
RIGEL PHARMACEUTICALS INC
UEI
X7MHPBCMHFM3
CAGE
60TS7
Registered address
611 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080, USA
Registration status
Active
Primary NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation
Dec 10, 2025
Initial registration
Jun 3, 2010
Entity start
Jun 14, 1996
SAM updated
Dec 10, 2025
Registration expires
Dec 10, 2026
Fiscal year end
Dec 31
Place of incorporation
DE, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
36F79724D000765 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARDDepartment of Veterans Affairs$19.5MOct 15, 2023Not available
75A50123C00012RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES…Department of Health and Human Services$750.0KMay 1, 2023Oct 31, 2025
Explore, filter and export all awards →SubcontractsGrants & subgrants

Registration, certifications & contacts

Registration evidenceDate
SAM updatedDec 10, 2025
Source loadedSep 26, 2026
Initial registrationJun 3, 2010
Entity startJun 14, 1996

Registration classifications: Small Business. These are separate from the reported certificates above.

IndustryReported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)Not reported
ContactRolePublished contact methodsEvidenceSource date
ARMAND LLARENAGovernment businessContact method not publishedSAM registrationNot available
ARMAND LLARENAElectronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

LEIDOS BIOMEDICAL RESEARCH INC

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
166 awards

THE EMMES COMPANY, LLC

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
73 awards

THE MITRE CORPORATION

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
59 awards

SRI INTERNATIONAL

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
59 awards

DUKE UNIVERSITY

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
43 awards

RESEARCH TRIANGLE INSTITUTE

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
41 awards

WESTAT, INC.

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
37 awards

REGENTS OF THE UNIVERSITY OF MINNESOTA

Repeated wins in this contractor's leading agency and category; not bid-level competitor proof
36 awards

About RIGEL PHARMACEUTICALS INC

What products and services appear in its federal awards?

Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); 325412 — Pharmaceutical Preparation Manufacturing.

Recorded products and services: AN15 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT; 6505 — Drugs and Biologicals.

Examples from recent award records:

These records describe federal award work, not every company capability. Review the award evidence.

Where is the company registered?

611 GATEWAY BLVD., SOUTH SAN FRANCISCO, California 94080, United States

Registered location from SAM.gov; award performance locations may differ.

Explore related contractor directories

Browse companies by registered location, primary registered industry, or federal customer.

Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

No official subaward rows are loaded, so Acorn does not claim known teaming relationships.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit